FP-008 (Fapon Biotech)

N/A

Report date: 2026/04/08 15:42:00

Base Information

Drug NameFP-008 (Fapon Biotech)
Drug Alias NameFP-008FP008
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion proteinBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionAnti-PD-1Interleukin-10 inhibitors
TargetsProgrammed cell death protein 1Interleukin-10
Therapy Area/IndicationsSolid tumoursNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesGuangdong Fapon Biopharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesZhuhai Fapon Biopharma Co Ltd
Inactive CompaniesGuangdong Fapon Biopharma Inc
Active IndicationsSolid tumours
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A